Earnings Call Insights: Eli Lilly and Company (NYSE:LLY) Q4 2024
Management View
- CEO David Ricks highlighted a 45% revenue growth in Q4, with significant contributions from Mounjaro and Zepbound. He emphasized ongoing expansion in manufacturing to meet demand and investments of over $23 billion